Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Arch Dermatol Res ; 312(10): 715-724, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-32166376

RESUMO

Hidradenitis suppurativa (HS) rarely affects pediatric patients. The literature on pediatric HS patients is scarce. This is a cross-sectional study based on case note review or interviews and clinical examination of 140 pediatric patients undergoing secondary or tertiary level care. Patients were predominantly female (75.5%, n = 105) with a median age of 16. 39% reported 1st-degree relative with HS. Median BMI percentile was 88, and 11% were smokers (n = 15). Median modified Sartorius score was 8.5. Notable comorbidities found were acne (32.8%, n = 45), hirsutism (19.3%, n = 27), and pilonidal cysts (16.4%, n = 23). Resorcinol (n = 27) and clindamycin (n = 25) were the most frequently used topical treatments. Patients were treated with tetracycline (n = 32), or oral clindamycin and rifampicin in combination (n = 29). Surgical excision was performed in 18 patients, deroofing in five and incision in seven patients. Obesity seemed to be prominent in the pediatric population and correlated to parent BMI, suggesting a potential for preventive measures for the family. Disease management appeared to be similar to that of adult HS, bearing in mind that the younger the patient, the milder the disease in majority of cases.


Assuntos
Antibacterianos/administração & dosagem , Procedimentos Cirúrgicos Dermatológicos , Hidradenite Supurativa/terapia , Obesidade/epidemiologia , Fumar/epidemiologia , Acne Vulgar/epidemiologia , Administração Cutânea , Administração Oral , Adolescente , Índice de Massa Corporal , Criança , Clindamicina/administração & dosagem , Comorbidade , Estudos Transversais , Quimioterapia Combinada/métodos , Feminino , Hidradenite Supurativa/epidemiologia , Hirsutismo/epidemiologia , Humanos , Masculino , Seio Pilonidal/epidemiologia , Resorcinóis/administração & dosagem , Rifampina/administração & dosagem , Fatores de Risco , Índice de Gravidade de Doença , Tetraciclina/administração & dosagem , Resultado do Tratamento , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA